Overview

Efficacy and Safety of Wharton's Jelly-Derived Mesenchymal Stem Cell Exosomes in the Treatment of Diabetic Foot Ulcers: A Double-blinded Randomized Controlled Clinical Trial

Status:
COMPLETED
Trial end date:
2024-09-02
Target enrollment:
Participant gender:
Summary
Study effeciency and safety of WJ-MSC derived exosomes in DFU healing
Phase:
PHASE1
Details
Lead Sponsor:
Kafrelsheikh University
Treatments:
Standard of Care